Doc Missling has matters well in hand. Three trial extensions getting underway THIS year, including a phase 2/3 AD. Also, moving ahead in PD and Rett Syndrome. Recent results re AD were stellar!
(0)
(0)
Anavex Life Sciences Corp. (AVXL) Stock Research Links